Загрузка...
End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
BACKGROUND: In men undergoing definitive radiation for prostate cancer, it is unclear whether early biochemical response can provide additional prognostic value beyond pre-treatment risk stratification. METHODS: Prostate cancer patients consecutively treated with definitive radiation at our institut...
Сохранить в:
| Опубликовано в: : | Prostate Cancer Prostatic Dis |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5429233/ https://ncbi.nlm.nih.gov/pubmed/28094250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2016.67 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|